These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 18803997

  • 41. Pill burden in hypertensive patients treated with single-pill combination therapy--an observational study.
    Hagendorff A, Freytag S, Müller A, Klebs S.
    Adv Ther; 2013 Apr; 30(4):406-19. PubMed ID: 23532555
    [Abstract] [Full Text] [Related]

  • 42. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
    Rump LC, Baranova E, Okopien B, Weisskopf M, Kandra A, Ferber P.
    Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
    [Abstract] [Full Text] [Related]

  • 43. [Antihypertensive therapy in routine practice: fixed or free combination? Fixed combination scores with better prognosis].
    MMW Fortschr Med; 2011 Sep 01; 153(35):46-7. PubMed ID: 21916307
    [No Abstract] [Full Text] [Related]

  • 44. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
    Fogari R, Zoppi A, Mugellini A, Corradi L, Lazzari P, Preti P, Derosa G.
    J Cardiovasc Pharmacol; 2008 Mar 01; 51(3):217-22. PubMed ID: 18356684
    [Abstract] [Full Text] [Related]

  • 45. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
    He YL, Ligueros-Saylan M, Sunkara G, Sabo R, Zhao C, Wang Y, Campestrini J, Pommier F, Dole K, Marion A, Dole WP, Howard D.
    J Clin Pharmacol; 2008 Jan 01; 48(1):85-95. PubMed ID: 17986525
    [Abstract] [Full Text] [Related]

  • 46. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
    Xie L, Frech-Tamas F, Marrett E, Baser O.
    Curr Med Res Opin; 2014 Dec 01; 30(12):2415-22. PubMed ID: 25222764
    [Abstract] [Full Text] [Related]

  • 47. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients.
    Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M.
    J Hum Hypertens; 2006 Oct 01; 20(10):787-94. PubMed ID: 16810279
    [Abstract] [Full Text] [Related]

  • 48. [Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study].
    Schühlen H, Abts M, Kastrati D.
    Herz; 2007 Aug 01; 32(5):419-25. PubMed ID: 17687532
    [Abstract] [Full Text] [Related]

  • 49. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension.
    Dezii CM.
    Manag Care; 2000 Sep 01; 9(9 Suppl):2-6. PubMed ID: 11729417
    [Abstract] [Full Text] [Related]

  • 50. Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine.
    Asmar R, Gosse P, Queré S, Achouba A.
    Blood Press Monit; 2011 Apr 01; 16(2):80-6. PubMed ID: 21372694
    [Abstract] [Full Text] [Related]

  • 51. Add-on benefits of amlodipine and thiazide in nondiabetic chronic kidney disease stage 1/2 patients treated with valsartan.
    Kaneshiro Y, Ichihara A, Sakoda M, Kurauchi-Mito A, Kinouchi K, Itoh H.
    Kidney Blood Press Res; 2009 Apr 01; 32(1):51-8. PubMed ID: 19258723
    [Abstract] [Full Text] [Related]

  • 52. Economic impact of switching from valsartan to other angiotensin receptor blockers in patients with hypertension.
    Signorovitch J, Zhang J, Wu EQ, Latremouille-Viau D, Yu AP, Dastani HB, Kahler KH.
    Curr Med Res Opin; 2010 Apr 01; 26(4):849-60. PubMed ID: 20141381
    [Abstract] [Full Text] [Related]

  • 53. Additional benefits of RAS blockade in the treatment of black hypertensives using valsartan/hydrochlorothiazide combination.
    Cardiovasc J S Afr; 2005 Apr 01; 16(5):285. PubMed ID: 16307164
    [No Abstract] [Full Text] [Related]

  • 54. [VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct 13; 93(42):1748. PubMed ID: 15529964
    [No Abstract] [Full Text] [Related]

  • 55. Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial.
    Conen D, Everett BM, Glynn RJ, Ridker PM.
    Heart; 2008 Mar 13; 94(3):e13. PubMed ID: 17923463
    [Abstract] [Full Text] [Related]

  • 56. Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension.
    Christogiannis LG, Kostapanos MS, Tellis CC, Milionis HJ, Tselepis AD, Elisaf MS.
    J Hum Hypertens; 2013 Jan 13; 27(1):44-50. PubMed ID: 22129607
    [Abstract] [Full Text] [Related]

  • 57. Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study.
    Yarows SA, Oparil S, Patel S, Fang H, Zhang J.
    Adv Ther; 2008 Dec 13; 25(12):1288-302. PubMed ID: 19066757
    [Abstract] [Full Text] [Related]

  • 58. Patient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care setting.
    Wogen J, Kreilick CA, Livornese RC, Yokoyama K, Frech F.
    J Manag Care Pharm; 2003 Dec 13; 9(5):424-9. PubMed ID: 14613440
    [Abstract] [Full Text] [Related]

  • 59. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P, Woestenburg A, Brié H, Vancayzeele S, MacDonald K, Denhaerynck K, Lee C, Hermans C, Abraham I.
    Ann Pharmacother; 2009 May 13; 43(5):849-61. PubMed ID: 19351876
    [Abstract] [Full Text] [Related]

  • 60. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
    Dickson M, Plauschinat CA.
    Am J Cardiovasc Drugs; 2008 May 13; 8(1):45-50. PubMed ID: 18303937
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.